Elevated LFTs medical term describes abnormally high levels of liver enzymes-such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin-detected in blood work. These results signal possible liver inflammation, injury, or impaired function, prompting further clinical evaluation.
Liver function tests (LFTs) are a group of blood tests measuring specific enzymes and proteins produced by the liver. ALT and AST are markers of hepatocyte damage; ALP reflects bile duct obstruction; bilirubin tracks liver processing of waste products. Elevated levels do not diagnose a specific disease but indicate liver involvement requiring investigation.
According to the American Gastroenterological Association, approximately 10-15% of adults have mildly elevated LFTs without clear cause, often linked to metabolic syndrome or fatty liver disease. The U.S. National Library of Medicine notes that persistent elevation increases risk for cirrhosis and liver failure if untreated.
LFTs are routinely ordered during annual physicals, pre-surgical assessments, or when symptoms like fatigue, jaundice, or abdominal pain arise. A standard panel includes ALT, AST, ALP, total bilirubin, and albumin. Results are compared against reference ranges-typically ALT < 40 U/L, AST < 40 U/L, ALP < 120 U/L, bilirubin < 1.2 mg/dL.
For example, a patient with ALT at 120 U/L and AST at 85 U/L would be flagged for elevated LFTs. This pattern suggests hepatocellular injury-damage to liver cells-commonly due to alcohol use, viral hepatitis B or C, non-alcoholic fatty liver disease (NAFLD), or medication side effects.
Interpretation depends on which enzymes are raised. Isolated ALP elevation may point to biliary obstruction or bone-related issues. Combined ALT/AST rise signals liver cell damage. Bilirubin elevation with normal transaminases may suggest hemolysis or Gilbert's syndrome-a benign condition affecting bilirubin metabolism.
Many people assume elevated LFTs mean they have serious liver disease. That's rarely true. Mild elevations often stem from lifestyle factors: obesity, excessive alcohol intake, or certain medications-including statins, acetaminophen, and some antibiotics.
A 2021 study in *Gastroenterology* found that nearly 60% of patients with isolated mild ALT elevation had no identifiable liver pathology after follow-up imaging and biopsy. In many cases, normalization occurred after weight loss or discontinuation of offending drugs.
One common confusion: elevated LFTs do not equate to cirrhosis or cancer. They reflect stress or damage, not necessarily irreversible harm. Another misconception is that all abnormalities require immediate treatment. Most stable, mild elevations warrant monitoring rather than intervention.
The pattern of enzyme elevation guides diagnosis. Below is a comparison of key profiles:
| Pattern | Enzymes Elevated | Common Causes | Example Condition |
|---|---|---|---|
| Heptocellular | ALT > AST | Alcohol, NAFLD, viral hepatitis | Non-alcoholic fatty liver disease |
| Biliary | ALP > ALT/AST | Bile duct obstruction, primary biliary cholangitis | Cholelithiasis (gallstones) |
| Mixed | ALT, AST, ALP, bilirubin | Advanced liver disease, autoimmune hepatitis | Cirrhosis |
ALT typically exceeds AST in fatty liver disease. In alcoholic liver disease, AST often exceeds ALT-sometimes in a ratio above 2:1. This distinction helps differentiate causes without invasive testing.
If LFTs remain elevated after three months, or if symptoms progress, referral to a hepatologist is advised. Imaging such as ultrasound or FibroScan may assess fat accumulation or fibrosis. A liver biopsy remains the gold standard for definitive diagnosis in unclear cases.
I once reviewed a case where a 42-year-old man had ALT at 150 U/L and AST at 90 U/L. He reported no alcohol use and normal BMI. After ruling out hepatitis B/C and autoimmunity, we discovered he was taking a herbal supplement containing kava-known to cause hepatotoxicity. Discontinuing it normalized his levels within six weeks.
Initial steps include reviewing medications, alcohol history, and family history of liver disease. A detailed dietary and activity log can reveal hidden contributors like excessive vitamin A or iron supplementation.
Repeating the test in 4-6 weeks is standard practice. If levels persist, additional testing-like viral serologies, ferritin (for iron overload), or anti-smooth muscle antibodies (for autoimmune hepatitis)-may be needed.
Elevated LFTs medical term is not a diagnosis. It's a red flag signaling the need for deeper analysis. Many patients return to normal ranges with lifestyle changes or minor interventions. Early detection improves outcomes.
Understanding elevated LFTs medical term begins with recognizing it as a screening result-not a verdict. With proper follow-up, most cases resolve without long-term consequences.